1. Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.
- Author
-
Mehta N, Huang S, Dhura R, Wambier C, do Nascimento Fonesca D, Little S, and Goren A
- Subjects
- Male, Humans, Administration, Topical, Sulfotransferases therapeutic use, Treatment Outcome, Minoxidil therapeutic use, Alopecia drug therapy, Alopecia chemically induced
- Abstract
Background: Minoxidil is the only US FDA approved topical drug for the treatment of androgenetic alopecia (AGA). Minoxidil is effective in hair re-growth in 30%-40% of patients and 50% of males. To exert its hair growing effect, minoxidil must be sulfonated in the scalp by the minoxidil sulfotransferase enzyme (SULT1A1). Low scalp SULT1A1 correlates with lack of minoxidil response; thus, supplementing the scalp SULT1A1 with naturally occurring minoxidil sulfotransferase enzymes could potentially improve treatment outcomes in AGA patients., Methods: In this study, we set to characterize SULT1A1 activity in various plants., Results: From the 10 common botanical extracts we have studied, seven exhibited significant activity toward minoxidil as a substrate; thus, providing a potential novel paradigm to increase minoxidil response with natural supplements., Conclusion: To the best of our knowledge, this is the first study to characterize naturally occurring minoxidil sulfotransferase enzymes in plants., (© 2023 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF